Cannabis Science & Technology - June 2022

Cannabis Science & Technology - June 2022

Issue link:

Contents of this Issue


Page 5 of 31

Psychedelics: New Frontiers in Alternative Medicine 6 contents c a n n a b i s s c i e n c e a n d t e c h n o l o g y ® | m a y / j u n e 2 0 2 2 | v o l 5 • n o s 1 8 The Path to Legalized, Accessible Psilocybin Therapy L A RRY BERE SFORD What would legalization and widespread availability of psilocybin therapy look like? Here, we connect with Dr. Sunil Aggarwal, a palliative care physician and cofounder of the Advanced Integrative Medical Science Institute (AIMS) in Seattle, Washington, to find out. 12 A New Clinical Trial in South Africa Aims to Study the Effect of Psilocybin on HIV Positive Women with Major Depressive Disorder ERIN MC E VOY In this interview, Donaghue Woodman, Head of Research and Development and Chief Medical Information Officer at Cannsun, provides an in-depth look at their current clinical trial on the effects of psilocybin in treating a prevalent yet unresolved issue in South Africa. 15 Anticipating Legalization: Making Psilocybin Accessible DE A N H A RRIS Here we present an outline of the areas that might be critical in creating an infrastructure for building the right psilocybin production space. 19 A Highly Contiguous Draft Reference Genome for the Psilocybe Cubensis Mushroom Is Now Available FR A NK PRIS C A RO A brief summary of a new peer-reviewed paper detailing the assembly of a highly contiguous draft reference genome for the Psilocybe cubensis mushroom by Kevin McKernan, Medicinal Genomics Chief Science Officer, and colleagues. 21 Psilocybin Therapy for PTSD and Depression J A ME S S C HWA R T Z An overview of the therapeutic role of psychedelics that goes back thousands of years, as well as the new research and the application of microdosing principles that have created renewed interest in the power of psychedelics. 8 on the cover: khamkula / 25 Cannabis and Psychedelics Research: A Conversation with Dr. Denise Vidot MEG A N L'HEUREU X Dr. Denise C. Vidot, an epidemiologist at the University of Miami and Founder of the International Cannabis & Psychedelic Research Collaborative, shares her research background, a short overview of her talk from this year's Cannabis Science Conferences West titled, "Co-Use of Cannabis and Psilocybin to Manage Mental Health Amid the COVID-19 Pandemic: Preliminary Results from the International COVID-19 Cannabis Health Study," and more. Follow us on social media for more updates on the cannabis industry! 6b9d44 @CannSciTech @CannabisSciTech 6b9d44 @CannabisScienceTechnology @CannabisScienceTechnology

Articles in this issue

Links on this page

view archives of Cannabis Science & Technology - June 2022 - Cannabis Science & Technology - June 2022